Clinical Trial Update: Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) [NA]

View source ↗

Summary

Clinical trial update on aripiprazole in children and adolescents with bipolar disorder and ADHD. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Federal University of Rio Grande do Sul | Conditions: Bipolar Disorder, Attention Deficit Hyperactivity Disorder | NA | Status: COMPLETED